List of Excipients in API cyclobenzaprine hcl
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cyclobenzaprine hcl
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | DIETHYL PHTHALATE | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | ETHYLCELLULOSE | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C BLUE NO. 1 | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C BLUE NO. 2 | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C RED NO. 40 | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C YELLOW NO. 6 | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | GELATIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cyclobenzaprine hcl
Detailed excipient profiles for cyclobenzaprine hcl
Excipient focus: CELLULOSE, MICROCRYSTALLINE
cyclobenzaprine hcl drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
cyclobenzaprine hcl drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
cyclobenzaprine hcl drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYL PHTHALATE
cyclobenzaprine hcl drug variants containing DIETHYL PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing DIETHYL PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
cyclobenzaprine hcl drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
cyclobenzaprine hcl drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
cyclobenzaprine hcl drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
cyclobenzaprine hcl drug variants containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
cyclobenzaprine hcl drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
cyclobenzaprine hcl drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
cyclobenzaprine hcl drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
cyclobenzaprine hcl drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
cyclobenzaprine hcl drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
cyclobenzaprine hcl drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
cyclobenzaprine hcl drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
cyclobenzaprine hcl drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
cyclobenzaprine hcl drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
cyclobenzaprine hcl drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
cyclobenzaprine hcl drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
cyclobenzaprine hcl drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cyclobenzaprine hcl drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links